Ken Griffin’s Citadel hedge fund places £305M short bet against GSK, with skepticism over long-term pipeline and recent stock rally.
Ken Griffin’s Citadel Places Big Short Bet Against GSK – Here’s What It Means for Investors
Where Today's News Shapes Tomorrow
